✦ LIBER ✦

Future directions in plasminogen activator therapy

✍ Scribed by Bode; M. S. Runge; E. Haber

Book ID: 112063007
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 742 KB
Volume: 13
Category: Article
ISSN: 0160-9289
DOI: 10.1002/clc.4960130602

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Future directions in immunomodulatory th

Future directions in immunomodulatory therapy

✍ Sagar Lonial 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 165 KB

Future directions in cardiac resynchroni

Future directions in cardiac resynchronization therapy

✍ Cecilia Linde 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 140 KB

Hyperacute Stroke Therapy With Tissue Pl

Hyperacute Stroke Therapy With Tissue Plasminogen Activator

✍ Mark J Alberts; MD 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 135 KB

WS037 Future directions in photodynamic

WS037 Future directions in photodynamic therapy

✍ J.M. Grevelink 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Future directions for temozolomide thera

Future directions for temozolomide therapy

✍ W.K.Alfred Yung 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Future directions for etoposide therapy

✍ F. Anthony Greco 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

Etoposide is an important chemotherapeutic agent in the treatment of selected patients with germ cell tumors, lymphomas, and small cell lung cancer (SCLC). Its optimal use is continuing to evolve. It is clear that schedule dependency is of critical importance. Recently, preliminary studies have sugg